Gemcitabine Hydrochloride was first introduced by Eli Lilly And Co in its drug Gemzar on May 15, 1996. Other drugs containing Gemcitabine Hydrochloride are Avgemsi, Gemcitabine Hydrochloride, Infugem. 27 different companies have introduced drugs containing Gemcitabine Hydrochloride.

Gemcitabine Hydrochloride Patents

Given below is the list of patents protecting Gemcitabine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Infugem	US9241948	Ready to be infused gemcetabine solution	Jul 01, 2033	Sun Pharm
Gemzar	US5464826 (Pediatric)	Method of treating tumors in mammals with 2',2'-difluoronucleosides	May 07, 2013 (Expired)	Lilly
Gemzar	US5464826	Method of treating tumors in mammals with 2',2'-difluoronucleosides	Nov 07, 2012 (Expired)	Lilly

Add above patents to watchlist

Gemcitabine Hydrochloride's Family Patents

Full family tree

Gemcitabine Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Gemcitabine Hydrochloride. The first generic version for Gemcitabine Hydrochloride was by Hospira Inc and was approved on Nov 15, 2010. And the latest generic version is by Hikma Pharmaceuticals International Ltd and was approved on Mar 7, 2023.

Given below is the list of companies who have filed for Gemcitabine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.